Issuu on Google+

A Background on Prostate Cancer and Other Stage 4 Cancer Protocols

Prostate concert in the early stage, has, for some time, been treated with surgery (in some cases drastic), radiation, chemotherapy, and medications that eliminate or block testosterone to increase survival. In fact, Davinci Robotic laparoscopic surgery has become enormously popular, but justifiably can only be recommended for early state prostate cancers. With late stage or stage 4 prostate cancer we typically witness more of the same as far as radiation and chemo are concerned, however, it is common to see adjunct forms of these treatments if the patient had grown refractory (i.e. lackluster response) to the first regimen. As metastasis begins, these treatments are proven to be ineffective and more likely to do more harm than good. Advancing to the forefront, Immunotherapy for stage 4 prostate cancer - a dramatic new way of targeting metastasis and dueling with the primary site of the cancer all at one time. Pertinent data clearly reflects that as tumors and cancer stages progress so do immune blocking mechanisms conjured (up regulated) by cancers to self-arm.

Advanced Stage 4 Prostate Cancer Treatment The field of cancer immunology now covers more than three decades and has developed rapidly, particularly over the prior 10 years. Immunotherapy, the use of the stimulated immune system to battle disease, has streamed out into different subsets


including immune system growth factors, monoclonal antibodies, cellular therapies, and even combinations of two or more of these strategies. Current advances in adoptive immunotherapy (focused on the expansion of specific disease-fighting white blood cells and their infusion into patients) have prompted stellar discoveries that have already been initiated and will continue to greatly impact stage 4 cancer treatment.

The Cells That Stage 4 Prostate Cancers Fear It is decidedly common knowledge among scientists and physicians that three types of white blood cells can be activated by the immune system to kill prostate and other stage 4 cancer cells: cytotoxic T lymphocytes (CTLs), natural killer cells (NKs), and natural killer T cells (NKTs). These cells can be found circulating in the body in low amounts; however, they are clearly a major first-line immune system defense against stage 4 prostate cancer.

Envita Leads the Field in Stage 4 Prostate Cancer Immunotherapy Multitudes of published studies have demonstrated the effects of adoptive immune therapy in stage 4 prostate cancer patients. Envita's renowned medical team assessed the best of these studies and focused on the strengths and weaknesses of each. Their findings established a protocol that incorporates only the best procedures for the expansion and application of cells as a powerful immunotherapy. Our protocols are based on the most recent published research in the field, from some of the most prestigious hospitals and universities in the nation and around the world. However, our immunology treatment has been specially designed to deal specifically with prostate cancer and stage 4 prostate cancer patients' immune systems.

AAIT for Stage 4 Prostate Cancer - Available at Envita Mexico The activated natural killer cells in Envita's AAIT stage 4 cancer vaccine are ostensibly more effective in the realm of tumor obliteration than other similar treatments accessed from across the globe. Supported by scientific research and clinical results, Envita's AAIT provides a powerful option for stage 4 prostate cancer patients who are determined to fight their disease, while keeping their immune system intact. If you have any queries concerning Envita’s AAIT stage 4 prostate cancer vaccine, please consult


with our expert team of physicians and patient educators. This particular stage 4 prostate cancer therapy is utilized in Envita Mexico's international cancer center.


A Background on Prostate Cancer and Other Stage 4 Cancer Protocols